Literature DB >> 11783950

A region upstream of the human delta-globin gene shows a stage-specific interaction with globin promoters in erythroid cell lines.

M Vitale1, R Calzolari, R Di Marzo, S Acuto, A Maggio.   

Abstract

We previously showed that the 651-bp DNA fragment, located 3 kb upstream from the human delta-globin gene (fragment F5), is able to inhibit adult, not fetal, globin promoter in mouse erythroleukemia cell lines (MEL) expressing adult globin genes. Here we show in transient analysis that fragment F5 has a strong inhibitory effect on fetal gamma-globin promoter in human erythroleukemia cell lines (HEL) expressing fetal globin genes. Since the beta-promoter constructs were poorly expressed in fetal cells, new plasmids containing an HPFH promoter (Ggamma(-175), T to C), which is strongly expressed in both fetal and adult cell lines, were made. Here we report that fragment F5 in HEL cells has a strong inhibitory effect on wild-type gamma-promoter only; no effect was evident on gamma(-175)-promoter in either MEL or HEL cell lines. Altogether these results show a stage-specific interaction between fragment F5 and globin promoters during development. We also report the presence of several bindings for erythroid GATA family factors by electrophoretic mobility shift assay, using nuclear extracts from erythroid cell lines. (c)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11783950     DOI: 10.1006/bcmd.2001.0447

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  2 in total

1.  Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin.

Authors:  Khaimuk Changsri; Varaporn Akkarapathumwong; Duangporn Jamsai; Pranee Winichagoon; Suthat Fucharoen
Journal:  Int J Hematol       Date:  2006-04       Impact factor: 2.490

2.  Transient expression assay of Agamma-588 (A/G) mutations in the K562 cell line.

Authors:  Mohammad Hamid; Frouzandeh Mahjoubi; Mohammad Taghi Akbari; Hossein Khanahmad; Fatemeh Jamshidi; Sirous Zeinali; Morteza Karimipoor
Journal:  Iran Biomed J       Date:  2011
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.